CD163 and Mental deterioration: Thus, in this study, we measured circulating markers of chronic inflammation (TNFR1, IL-6), markers of innate immune activation (CD14 and CD163), and an adaptive immunity marker (CD25, a marker of T-cell activity) to determine whether these measures are associated with cognitive decline and incidence of MCI.